Legacy Education (LGCY) Q3 2026 earnings review
Top-Line Growth Decelerates Sharply as Student Starts Reverse
Legacy Education delivered 15% revenue growth to $21.4M and slight EPS growth in Q3, but the underlying momentum is cracking. After four consecutive quarters of ~40% revenue expansion, growth is rapidly decelerating. The most alarming metric is a 12% YoY decline in new student starts. Management cited 'steady enrollment trends,' but the data directly contradicts this. While operational efficiency at the campus level improved gross margins, escalating G&A costs—driven by marketing and recurring bad debt—are capping profit leverage.
🐂 Bull Case
Educational services expense declined from 54.4% to 51.7% of revenue. The company is extracting more margin from its existing student base through optimized employee compensation and facility utilization.
The launch of Surgical Technology AAS and Sterile Processing Technician programs at the High Desert and Integrity campuses diversifies the revenue base and aligns with high-demand allied health verticals.
🐻 Bear Case
New student starts reversed from +49% YoY growth in Q2 to a -12% YoY contraction in Q3 (1,078 vs 1,227). If the top of the funnel is shrinking, future revenue deceleration is practically guaranteed.
Marketing spend jumped to $1.5M (up from $1.2M), yet new student starts fell. Paying more money to acquire fewer students is a toxic formula for operating leverage.
⚖️ Verdict: 🔴
Bearish. The 15% revenue growth masks a concerning reversal in the primary leading indicator: new student starts. Combined with rising bad debt and increased marketing spend yielding fewer students, the operational leverage story is severely damaged.
Key Themes
Reversing Leading Indicators Contradict Management Tone
Management's press release cited 'steady enrollment trends,' yet the raw data shows new student starts fell 12% YoY (from 1,227 to 1,078). This is a stark Reversal from the 49% growth seen just last quarter. Because student starts represent future tuition streams, this drop guarantees severe revenue deceleration in upcoming quarters unless immediately fixed.
G&A Bloat and Persistent Bad Debt
General and administrative expenses surged 33.5% YoY to $6.2M. Management explicitly cited 'bad debt' as a primary driver. In FY25, Legacy took a surprise $700,000 AR reserve due to graduate payment softness. The reappearance of bad debt as a headwind suggests their new collections partnership has not fully resolved the underlying issue of uncollectible tuition.
M&A Execution Deadline Missed?
Throughout H1 26, management heavily promoted an active M&A pipeline, confidently stating their goal to 'announce a deal within the fiscal year' to scale multi-campus operations. Q3 materials only note a 'Branch Letter of Intent executed.' Without a major acquisition, the company must rely entirely on organic growth—which is currently decelerating.
Educational Delivery Efficiencies
Despite higher externship fees, Legacy successfully improved its gross delivery margins. Educational services dropped to 51.7% of revenue from 54.4% YoY. This Stable improvement proves the hybrid 'tech-and-touch' delivery model is effectively keeping core instructional and facility costs contained even as the total student population grows.
Strategic Program Rollouts
The company launched the Surgical Technology AAS and Sterile Processing Technician programs at its High Desert Medical College, alongside a Sterile Processing program at the Integrity College of Health. By targeting highly specialized technician roles, Legacy avoids oversaturated generic medical assistant markets.
Macro Tailwind: Healthcare Labor Shortage
The underlying thesis remains intact: the U.S. faces a projected 1.9 million annual healthcare job openings through 2034. While Legacy's execution has stumbled this quarter, the structural demand for the certified professionals they produce provides a permanent floor for the business.
Other KPIs
Decelerating. Grew 12.6% YoY, lagging the 15.0% revenue growth. Adjusted EBITDA margin compressed slightly as massive 33% increases in G&A wiped out the 270 bps of efficiency gained on the educational delivery side.
Decelerating sharply. Net income grew just 7.5% YoY, a massive slowdown compared to the 46% and 50% leaps seen in the first two quarters of the fiscal year. Higher marketing spend to chase fewer students is heavily pressuring the bottom line.
Stable. Up from $20.6M in Q1. The balance sheet remains highly liquid with strong working capital ($30.8M), giving the company plenty of ammunition to execute on M&A or greenfield branch expansions if organic starts remain suppressed.
Guidance
Management declined to provide quantitative forward guidance. They qualitatively stated they see 'strong interest' and 'steady enrollment trends,' a claim that requires heavy scrutiny given the 12% YoY decline in Q3 new student starts.
Key Questions
Collapse in Student Starts
New student starts fell 12% YoY this quarter after growing nearly 50% last quarter. What specifically caused this whiplash? Is this a capacity constraint issue, or is demand at existing campuses drying up?
Bad Debt Resurgence
You cited bad debt as a driver for the 33% increase in G&A. Following the $700k AR reserve taken in FY25, what is the current AR reserve percentage, and is the softness in graduate payments getting worse?
Marketing Inefficiencies
Marketing spend increased from $1.2M to $1.5M, yet it yielded roughly 150 fewer new student starts compared to the same period last year. Why are customer acquisition costs suddenly spiking?
M&A Timeline Delay
In previous calls, you confidently guided toward announcing a multi-campus acquisition within this fiscal year. The current release only mentions a branch LOI. Has the timeline for a major acquisition been pushed back?